Arthur A. Levin, a director at Avidity Biosciences, Inc. (NASDAQ:RNA), recently sold 1,872 shares of the company's common stock. The shares were sold at a weighted-average price of $28.60, totaling ...
Michael F. MacLean, Chief Financial Officer of Avidity Biosciences, Inc. (NASDAQ:RNA), recently sold shares of the company ...
Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more, the method relies upon mineral-coated microparticles to deliver mRNA that encodes for ...
The Kowalinski group at EMBL Grenoble discovered notable differences between the nuclear cap-binding complex in trypanosomes and humans, a critical component in cellular RNA metabolism. Trypanosomes ...
Researchers at the University of Copenhagen and NTU Singapore have discovered that RNA damage, not DNA damage, is the real trigger for the acute effec ...
In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.
The integration will enable Leica’s BOND staining systems to simultaneously detect RNA and protein targets on the same tissue ...
Spending enough time in the sun without adequate protection can leave us looking and presumably feeling like a lobster ready ...
New research reveals that sunburn’s acute effects, like inflammation and cell death, are triggered by RNA damage rather than ...
University of Wisconsin–Madison researchers have developed a promising technique for treating osteoarthritis using ...
DNA-nanoparticle motors are exactly as they sound: tiny artificial motors that use the structures of DNA and RNA to propel ...
Exploring use of Altamira's RNA nanoparticles in conjunction with radiopharmaceutical cancer treatment Project collaboration partner will have option ...